Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Share-based Compensation (2016 - 2025)

Historic Share-based Compensation for National Healthcare (NHC) over the last 17 years, with Q3 2025 value amounting to $1.2 million.

  • National Healthcare's Share-based Compensation rose 1335.77% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 million, marking a year-over-year increase of 2340.94%. This contributed to the annual value of $4.2 million for FY2024, which is 4953.27% up from last year.
  • National Healthcare's Share-based Compensation amounted to $1.2 million in Q3 2025, which was up 1335.77% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, National Healthcare's Share-based Compensation registered a high of $1.2 million during Q3 2025, and its lowest value of $496000.0 during Q1 2021.
  • Moreover, its 5-year median value for Share-based Compensation was $715000.0 (2021), whereas its average is $824894.7.
  • As far as peak fluctuations go, National Healthcare's Share-based Compensation crashed by 1701.09% in 2021, and later skyrocketed by 6561.09% in 2024.
  • Quarter analysis of 5 years shows National Healthcare's Share-based Compensation stood at $715000.0 in 2021, then decreased by 11.61% to $632000.0 in 2022, then grew by 4.91% to $663000.0 in 2023, then surged by 65.61% to $1.1 million in 2024, then increased by 12.84% to $1.2 million in 2025.
  • Its Share-based Compensation was $1.2 million in Q3 2025, compared to $1.2 million in Q2 2025 and $1.0 million in Q1 2025.